FDA recall, , Moderate risk
Norbrook Noromycin 300 LA Oxytetracycline Injection
Noromycin 300 LA antibiotic lacks assurance of sterility.
Summary by Recall Canary from the FDA notice
What happened
MWI Animal Health recalled Noromycin 300 LA (oxytetracycline injection) antibiotic, manufactured by Norbrook Laboratories Limited, Newry, Northern Ireland, due to lack of assurance of sterility. The recall began March 13, 2026, and was added to FDA's Enforcement Report on March 19, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for recalled products:
- Check the brand, package size and codes such as expiration dates against the notice.
- Return it to the store where you bought it, or dispose of it properly.
Is your carton affected?
Affected if its lot code matches.
Carton: Noromycin 300 LA (oxytetracycline injection) ANTIBIOTIC, Manufactured by: Norbrook Laboratories Limited, Newry, Northern Ireland, NADA# 141-143.
- Lot code
- 4501-600A
Recall details
- Company began the recall
- Sold in
Within U.S
- Company
- MWI Animal Health
- Hazard
- Sterility problem
- Risk
Moderate risk
It may cause short-term health problems in animals it is used on, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98532
- Recall number
- V-0110-2026
- Quantity recalled
- 196 units. See 4b in Attach. B
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
In FDA's weekly enforcement report
Classified by FDA
Listed on Recall Canary
Summary updated
